High-dose methotrexate for elderly patients with primary CNS lymphoma
Open Access
- 1 April 2009
- journal article
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 11 (2), 211-215
- https://doi.org/10.1215/15228517-2008-067
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Primary Central Nervous System Lymphoma: The Memorial Sloan-Kettering Cancer Center Prognostic ModelJournal of Clinical Oncology, 2006
- Long-Term Follow-Up of High-Dose Methotrexate-Based Therapy With and Without Whole Brain Irradiation for Newly Diagnosed Primary CNS LymphomaJournal of Clinical Oncology, 2006
- Whole-brain radiotherapy and high-dose methylprednisolone for elderly patients with primary central nervous system lymphoma: Results of North Central Cancer Treatment Group (NCCTG) 96-73-51International Journal of Radiation Oncology*Biology*Physics, 2006
- Gene expression and angiotropism in primary CNS lymphomaBlood, 2006
- Report of an International Workshop to Standardize Baseline Evaluation and Response Criteria for Primary CNS LymphomaJournal of Clinical Oncology, 2005
- High-dose methotrexate toxicity in elderly patients with primary central nervous system lymphomaAnnals Of Oncology, 2005
- Primary Central Nervous System Lymphoma: Results of a Pilot and Phase II Study of Systemic and Intraventricular Chemotherapy With Deferred RadiotherapyJournal of Clinical Oncology, 2003
- Chemotherapy Alone as Initial Treatment for Primary CNS Lymphoma in Patients Older Than 60 Years: A Multicenter Phase II Study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor GroupJournal of Clinical Oncology, 2003
- High-dose methotrexate for primary CNS lymphoma in the elderlyNeuro-Oncology, 2000
- High-dose methotrexate for primary CNS lymphoma in the elderlyNeuro-Oncology, 2000